SAN DIEGO, CA., November 3, 2015—Acutus Medical, a global heart rhythm technology company, today announced that data showing the potential advantage the AcQMap™ High Resolution Imaging and Mapping System can provide to electrophysiologists during atrial fibrillation (AF) procedures will be presented at the 2015 American Heart Association Scientific Sessions held Orlando, Florida from November 7-11, 2015. Data from the study discussed in the poster were previously reported by the Company at the 10th annual Heart Rhythm Congress.

Details of the poster presentation are as follows:

• Presentation Title: Novel Global Ultrasound Imaging and Continuous Dipole Density Mapping: Initial Findings in AF Patients
• Presenter: Dr. Andrew Grace, M.D., Papworth Hospital/Cambridge University, Cambridge, United Kingdom
• Session Day and Time: Monday, November 9, 2015 from 9:00 am to 10:15 am ET
• Location: Poster Hall A2 / Orange County Convention Center
• Poster Number: #4089
• Session Title: Treatment of Arrhythmias: Evaluating Technologies for Ablation of Arrhythmias

About AcQMap™ High Resolution Imaging and Mapping System
The AcQMap™ High Resolution Imaging and Mapping System is the first and only system to detect and display both standard voltage-based maps as well as the higher resolution charge-source (dipole density) maps through a set of proprietary algorithms. The system is also able generate real-time, ultrasound images of the heart chamber with quality comparable to a CT or MRI in a matter of minutes.

About Acutus Medical
Acutus Medical is a global heart rhythm technology company committed to revolutionizing the way electrophysiologists (EPs) diagnose and treat cardiac arrhythmias. The company is currently pursuing CE mark approval in Europe for the full suite of AcQMap™ System products. Acutus Medical is a privately held company located in San Diego, CA. To learn more, visit www.acutusmedical.mccdesign.com.

Forward Looking Statements
This document includes forward-looking statements regarding Acutus Medical’s Cardiac Imaging and Mapping Technology System. Any statement describing Acutus Medical’s goals, expectations, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Acutus goals. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing products and in the endeavor of building a business around such products. Acutus Medical’s forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Acutus Medical forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Acutus Medical. As a result, you are cautioned not to rely on these forward-looking statements.

Media Contact:
Susan Heins
(864) 346-8336
susan@purecommunicationsinc.com

Investor Contact:
Matt Clawson
(949) 370-8500
matt@purecommunicationsinc.com